By Fineline Cube 
Wuxi-based Pulnovo Medical Limited, a developer of medical devices for hypertension and heart failure, announced that it has raised “tens of millions” of US dollars in a new financing round. The round was led by EQT Group, a top-tier global private equity firm, with contributions from existing investor Qiming Venture Partners.
Funding and Future Plans
Proceeds from the financing will be used to accelerate the company’s global expansion. This includes supporting international clinical trials, regulatory approvals, indication expansion, and commercialization efforts. The funding aims to further establish Pulnovo Medical as a leader in the global medical device market.
Company Milestones
Pulnovo Medical has already commercialized its in-house developed percutaneous pulmonary denervation (PADN) series catheter and host. The company is also conducting multiple clinical programs around the globe. Earlier this year, Pulnovo Medical closed a USD 100 million Series C financing round in March, highlighting its ongoing growth and market presence.-Fineline Info & Tech